CN105535414A - Health food composition with gastric mucosal damage auxiliary protection function - Google Patents
Health food composition with gastric mucosal damage auxiliary protection function Download PDFInfo
- Publication number
- CN105535414A CN105535414A CN201511020011.7A CN201511020011A CN105535414A CN 105535414 A CN105535414 A CN 105535414A CN 201511020011 A CN201511020011 A CN 201511020011A CN 105535414 A CN105535414 A CN 105535414A
- Authority
- CN
- China
- Prior art keywords
- weight portion
- chinese medicine
- parts
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000006378 damage Effects 0.000 title claims abstract description 28
- 235000013402 health food Nutrition 0.000 title claims abstract description 10
- 230000002496 gastric effect Effects 0.000 title abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 34
- 238000002360 preparation method Methods 0.000 claims abstract description 24
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 36
- 210000001156 gastric mucosa Anatomy 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 208000027418 Wounds and injury Diseases 0.000 claims description 19
- 208000014674 injury Diseases 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 239000013543 active substance Substances 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 14
- 238000009472 formulation Methods 0.000 claims description 12
- 239000012567 medical material Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 8
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 238000004321 preservation Methods 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 241000049624 Alisma plantago-aquatica subsp. orientale Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 229960004756 ethanol Drugs 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- -1 Dichlorodiphenyl Acetate Chemical compound 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000004265 Stomach Rupture Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000027119 gastric acid secretion Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 108060006613 prolamin Proteins 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000019890 Amylum Nutrition 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 240000000588 Hericium erinaceus Species 0.000 description 1
- 235000007328 Hericium erinaceus Nutrition 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010048725 Hydropneumothorax Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000003898 Mediastinal Emphysema Diseases 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010050184 Pneumomediastinum Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042344 Subcutaneous emphysema Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000021271 drinking Nutrition 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021222 fish soup Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001370 mediastinum Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004682 mucosal barrier function Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/55—Liquid-liquid separation; Phase separation
Abstract
The invention relates to an application of a traditional Chinese medicine composition in preparation of a health food with a gastric mucosal damage auxiliary protection function. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 30-80 parts of lily, 30-80 parts of tuckahoe, 40-90 parts of figwort root, 30-80 parts of Szechuan lovage rhizome, 20-60 parts of oriental waterplantain rhizome, 5-30 parts of notoginseng, 10-50 parts of largehead atractylodes rhizome, 20-60 parts of Chinese angelica, 20-60 parts of pollen typhae, and 120-180 parts of white peony root.
Description
Invention field
The present invention relates to a kind of preparation method of Chinese medicine and health food compositions, particularly there is the pharmaceutical preparation that gastric mucosa injury has the preparation method of the health-care food composition of assistant protection function and prepares by the method.
Background technology
Whole inner surfacies of stomach are covered with one deck mucosal tissue, can secreting mucus, form the mucus one mucosal barrier protection gastric tissue of stomach.Gastric mucosa injury is more common in gastritis, gastric ulcer.Often due to chemical factor (smoking, drink, strong tea, coffee and stimulate the medicine of gastric mucosa as aspirin, indometacin etc.), caused by physical factor (supercool, excessively boiling hot, too coarse food or eating and drinking too much at one meal etc.), the factor such as antibacterial or its toxin stimulation.
Gastric mucosa injury is divided into the coat of the stomach damage stomach function regulating disruptiveness damage of breaking without holostrome, and the coat of the stomach damage of breaking without holostrome without obvious clinical symptoms, or can only have the mild pain of epigastrium, takes a turn for the better gradually after clinical observation.
Gastric rupture damage major systemic performance be shock and hemorrhage; Abdominal part presents peritoneal irritation sign more.
After gastric rupture, often there is stomachache immediately, abdominal distention and diffusivity peritoneal irritation sign, it is rare to vomit, can dyspnea be there is in abdominal distention severe patient, damaged mouth close to cardia, during esophagus district, mediastinal emphysema is caused because air can enter mediastinum, hydropneumothorax, chest subcutaneous emphysema, when gastric injury is larger, can to gush out indigested food from abdominal wound, bile and gas; Can also see the stomach split once in a while, some case can in abdominal subcutaneous edema due to disorder of QI in various degree, and liver dullness circle reduces or disappears, and shifting dullness can be positive, hypoactive bowel sounds or disappearance, if be associated with other organs damage, and can with corresponding sings and symptoms.
Protection gastric mucosa comprises following methods:
1. protect the food stomach of gastric mucosa expensive in " supporting " but not " controlling ", suitable diet content and good dietary habit are the important measures preventing and treating gastric mucosa injury.Diet gastric mucosa being had to intense stimulus should be limited, and utilize diet to reduce or increase the secretion of gastric acid, regulate stomach function.Very few to gastric acid secretion or lack patient, can give the food stimulus gastric acid secretion such as concentrated fish soup, chicken soup, mushroom soup of rich nitrogen extractum.The patient of gastroxia then should avoid above-mentioned natural juice thick soup, adopt remove former soup after boiling lean meat, fish, Carnis Gallus domesticus, and Amylum Nelumbinis Rhizomatis, weak tea, various sweet fruit to boil water, dense rice water, congee etc., gastric secretion is reduced, and the steamed bread of edible fresh milk, bean milk, band alkali dry with in and gastric acid.The medicated porridge that rice or Semen setariae are boiled into has the intestines and stomach coordinating function.
2 have the health product or medicine of protecting gastric mucosa effect.Known prolamin has repairs gastric mucosa effect, material in prolamin can the muscle protein of targeted stimulation human gastrointestinal tract and the synthesis of glycogen, the generation of human stomach mucosa can be improved, promote gastric motility, be known to gastrointestinal disease such as solution intractable gastritis and gastric ulcers to effective native protein, clinical effectiveness is remarkable.As the health food being raw material with the Chinese herbal medicine of invigorating the spleen and benefiting QI nourishing the stomach effect.Conventional has the Rhizoma Dioscoreae of invigorating the spleen and benefiting QI class, the Fructus Amomi of class of regulating the flow of vital energy, the Fructus Gardeniae etc. of heat clearing away class.Other have good protective effect to gastric mucosa as Hericium erinaceus (Bull. Ex Fr.) Pers., and the Total saponin tool contained by the Radix Astragali, Radix Codonopsis, Radix Ginseng is antibacterial, antiviral and improve immunity, effective to the gastric mucosa injury caused by infecting.The health food being raw material with these compositions has protection gastric mucosa effect preferably.
The present inventor finds in clinical and production practices; prior art formula amount is large; medical material waste is serious; oral difficulty; and do not report that above-mentioned preparation had effect that gastric mucosa injury has the health food of assistant protection function; the present invention improves formula on the basis of existing technology, deletes the expensive medical material of part, the research work adopt the Chinese crude drug of medicine-food two-purpose in formula, having carried out in health food.The present invention, through experimentation, finds unexpectedly, and formula of the present invention has health food effect that gastric mucosa injury has assistant protection function, thus completes the present invention.
Summary of the invention:
The invention provides a kind of Chinese medicine composition in preparation, to there is gastric mucosa injury and have application in the health food of assistant protection function,
Described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion, Bulbus Lilii 30-80 weight portion, Poria 30-80 weight portion, Radix Scrophulariae 40-90 weight portion, Rhizoma Chuanxiong 30-80 weight portion, Rhizoma Alismatis 20-60 weight portion, Radix Notoginseng 5-30 weight portion, Rhizoma Atractylodis Macrocephalae 10-50 weight portion, Radix Angelicae Sinensis 20-60 weight portion, Pollen Typhae 20-60 weight portion, Radix Paeoniae Alba 120-180 weight portion
Preferably, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion, Bulbus Lilii 60 weight portion, Poria 60 weight portion, Radix Scrophulariae 75 weight portion, Rhizoma Chuanxiong 45 weight portion, Rhizoma Alismatis 45 weight portion, Radix Notoginseng 15 weight portion, the Rhizoma Atractylodis Macrocephalae 30 weight portion, Radix Angelicae Sinensis 45 weight portion, Pollen Typhae 45 weight portion, the Radix Paeoniae Alba 150 weight portion
More than in composition, weight calculates with crude drug, more than composition is by weight as proportioning, can increase according to corresponding proportion when producing or reduce, as large-scale production can by kilogram in units of, or in units of ton, small-scale production also can by gram or milligram in units of, weight can increase or reduce, but the constant rate of raw medicinal herbs weight proportion between each composition.
Compositions of the present invention, preferred preparation method, step is as follows:
Medical material decocts with water 1-3 time, each 1.5-3 hour, collecting decoction, and filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 60-80%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filters, obtains active substance, be then prepared into Halth-care composition.
Most preferred, described Chinese medicine composition preparation method step is as follows:
Medical material decocts with water 2 times, each 2 hours, collecting decoction, and filter, filtrate is concentrated in right amount, adds ethanol, make alcohol content reach 7%, leave standstill, filter, reclaim ethanol, filtrate concentrates, add water cold preservation, filters, obtain active substance, through formulation method, be then prepared into Halth-care composition.
The preparation of said products can adopt conventional manufacturing techniques, as using active substance of the present invention as active component, adds adjuvant if desired, as sweeting agent, correctives, the galenic pharmacy routine techniques such as excipient is prepared into tablet, capsule etc., or be prepared into food with food routine techniques.Compositions of the present invention can be that any one is applicable to oral dosage form, as tablet, and capsule, granule, oral liquid, powder, pills etc., also can be prepared into applicable edible food form, as caked sugar, cookies, milk product, ice lolly, bread, fruit jam etc.
Fang Zhong, Bulbus Lilii, Radix Scrophulariae yin nourishing stomach reinforcing are monarch drug, and Radix Angelicae Sinensis, the Radix Paeoniae Alba, Rhizoma Chuanxiong, Pollen Typhae, Radix Notoginseng blood nourishing acupuncture-stimulating are accessory drugs, and the Rhizoma Atractylodis Macrocephalae, Poria, Rhizoma Alismatis invigorating spleen to remove dampness are adjuvant drug, QI and blood is prosperous, taste and, naturally pain only disease remove.Experiment proved kind conventional amount used use safety, in side, composition cooperatively interacts and has synergistic function.
Compared to the prior art, difference is method of the present invention, provides a kind of new purposes, below by way of experimental data, beneficial effect of the present invention is described:
Testing medicine used is the active substance prepared according to the method for the embodiment of the present invention 1, is called invention formulation,
The impact of experiment 1 on mice paper ear swelling
The impact of experiment 2 on mice hot plate reaction
Test the impact of 3 Dichlorodiphenyl Acetate induced mice writhing responses
The impact of experiment 4 on the emptying motion of Mouse Stomach
Experimental result is in Table 1-4.
Table 1 invention formulation is on the impact of mice paper ear swelling
Table 2 invention formulation is on the impact of mice hot plate reaction
The impact of table 3 invention formulation Dichlorodiphenyl Acetate induced mice writhing response
Table 4 invention formulation is on the impact of the emptying motion of Mouse Stomach
Enhancing immunity is tested
Must affect, in table 5 mouse thymus/weight ratio and spleen/weight ratio:
Table 5 is on the impact of mouse immune organ internal organs/weight ratio
On the impact of mouse cell immunologic function, in table 6,7:
Table 6 pair mouse lymphocyte conversion capability experimental result (lymphopoiesis ability)
Table 7 is on mice delayed allergy (the sufficient sole of the foot thickens method) impact (sufficient sole of the foot thickness difference mm)
On the impact of mouse antibodies cellulation, in table 8:
Table 8 is on mouse antibodies cellulation number impact (plaque number/106 splenocyte)
On mouse monokaryon--the impact of macrophage function, in table 9:
Table 9 is on mouse monokaryon--the impact (phagocytic index) of macrophage carbonic clearance
The protective effect of gastric mucosa injury
Experimental technique:
Get body weight and be 180 ~ 220g and the rat of water 48h is can't help in fasting, be divided at random blank group, of the present invention group, by 10ml//kg body weight gavage distilled water or Radix Aucklandiae extract, every rat oral gavage 1.5ml hydrochloric acid-alcohol mixeding liquid after 40min, after 40min, de-cervical vertebra puts to death rat, opens abdomen and gets stomach, use clamp cardia, inject 1% formalin 5ml by pylorus, clamping pylorus, is placed in 1% formalin by full stomach and fixes 10min.Cut off along greater gastric curvature, stomach is turned up, wash away gastric content gently with clear water.Stomach is laid on glass plate, by ruler measurement gastric mucosa injury length, using damaged length (damage width is greater than 1mm person to be doubled to calculate) summation as Gastric mucosal injury index, carry out statistical procedures, and calculating injury tolerance: result shows, of the present invention group of injury tolerance is 36.2%, and blank group is 91.5%.
Carry out the Protection to Mouse Gastric Mucous Membrane damage in addition; method is: dehydrated alcohol method, aspirin method, water logging stress method and reserpine legal system for Mouse Gastric Mucous Membrane damage model; gastric mucosa injury area after medicine is measured, result: medicine of the present invention all has inhibitory action in various degree to four kinds of gastric mucosa injurys after using medicine of the present invention.
Detailed description of the invention:
Further illustrate the present invention by the following examples, but not as limitation of the present invention.
Embodiment 1
Embodiment 1
Bulbus Lilii 60 weight portion, Poria 60 weight portion, Radix Scrophulariae 75 weight portion, Rhizoma Chuanxiong 45 weight portion, Endothelium Corneum Gigeriae Galli 15 weight portion, Rhizoma Alismatis 45 weight portion, Radix Notoginseng 15 weight portion, the Rhizoma Atractylodis Macrocephalae 30 weight portion, Radix Angelicae Sinensis 45 weight portion, Radix Sanguisorbae 75 weight portion, Pollen Typhae 45 weight portion, the Radix Paeoniae Alba 150 weight portion, Herba Dendrobii 75 weight portion.
Its preparation method is as follows:
Medical material decocts with water 2 times, each 2 hours, collecting decoction, and filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 70%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filters, obtains active substance, be prepared into pill further according to galenic pharmacy routine techniques.
Embodiment 2
Bulbus Lilii 30 weight portion, Poria 30 weight portion, Radix Scrophulariae 40 weight portion, Rhizoma Chuanxiong 30 weight portion, Rhizoma Alismatis 20 weight portion, Radix Notoginseng 5 weight portion, the Rhizoma Atractylodis Macrocephalae 10 weight portion, Radix Angelicae Sinensis 20 weight portion, Pollen Typhae 20 weight portion, the Radix Paeoniae Alba 120 weight portion
Its preparation method is as follows:
Medical material decocts with water 1 time, each 1.5 hours, collecting decoction, and filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 60%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filters, obtains active substance, be prepared into tablet further according to galenic pharmacy routine techniques.
Embodiment 3
Bulbus Lilii 80 weight portion, Poria 80 weight portion, Radix Scrophulariae 90 weight portion, Rhizoma Chuanxiong 80 weight portion, Rhizoma Alismatis 60 weight portion, Radix Notoginseng 30 weight portion, the Rhizoma Atractylodis Macrocephalae 50 weight portion, Radix Angelicae Sinensis 60 weight portion, Pollen Typhae 60 weight portion, the Radix Paeoniae Alba 180 weight portion
Its preparation method is as follows:
Medical material decocts with water 3 times, each 3 hours, collecting decoction, and filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 80%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filters, obtains active substance, be prepared into granule further according to galenic pharmacy routine techniques.
Embodiment 4
The preparation of capsule
The pharmaceutically active substance that Example 1 obtains, through the formulation preparation method of routine, is prepared into capsule
Embodiment 5
The preparation of tablet
The pharmaceutically active substance that Example 1 obtains, through the formulation preparation method of routine, is prepared into tablet
Embodiment 6
The preparation of pill
The pharmaceutically active substance that Example 1 obtains, through the formulation preparation method of routine, is prepared into pill
Embodiment 7
The preparation of granule
The pharmaceutically active substance that Example 1 obtains, through the formulation preparation method of routine, is prepared into granule
Embodiment 8
The preparation of oral liquid
The pharmaceutically active substance that Example 1 obtains, through the formulation preparation method of routine, is prepared into oral solutions.
Claims (6)
1. Chinese medicine composition has gastric mucosa injury in preparation and has an application in the health food of assistant protection function, and described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
Bulbus Lilii 30-80 weight portion, Poria 30-80 weight portion, Radix Scrophulariae 40-90 weight portion, Rhizoma Chuanxiong 30-80 weight portion, Rhizoma Alismatis 20-60 weight portion, Radix Notoginseng 5-30 weight portion, Rhizoma Atractylodis Macrocephalae 10-50 weight portion, Radix Angelicae Sinensis 20-60 weight portion, Pollen Typhae 20-60 weight portion, Radix Paeoniae Alba 120-180 weight portion.
2. application according to claim 1, is characterized in that, described Chinese medicine composition is prepared from by the raw material of Chinese medicine medicine of following weight proportion,
Bulbus Lilii 60 weight portion, Poria 60 weight portion, Radix Scrophulariae 75 weight portion, Rhizoma Chuanxiong 45 weight portion, Rhizoma Alismatis 45 weight portion, Radix Notoginseng 15 weight portion, the Rhizoma Atractylodis Macrocephalae 30 weight portion, Radix Angelicae Sinensis 45 weight portion, Pollen Typhae 45 weight portion, the Radix Paeoniae Alba 150 weight portion.
3. application according to claim 1, is characterized in that, wherein said Chinese medicine composition preparation method step is as follows:
Medical material decocts with water 1-3 time, each 1.5-3 hour, collecting decoction, and filter, filtrate is concentrated in right amount, add ethanol, make alcohol content reach 60-80%, leave standstill, filter, reclaim ethanol, filtrate concentrates, and add water cold preservation, filters, obtains active substance, be then prepared into Halth-care composition.
4. application according to claim 3, is characterized in that, wherein said Chinese medicine composition preparation method step is as follows:
Medical material decocts with water 2 times, each 2 hours, collecting decoction, and filter, filtrate is concentrated in right amount, adds ethanol, make alcohol content reach 7%, leave standstill, filter, reclaim ethanol, filtrate concentrates, add water cold preservation, filters, obtain active substance, through formulation method, be then prepared into Halth-care composition.
5. application according to claim 1, is characterized in that, described Chinese medicine composition is the pharmaceutical dosage form that any one can be taken.
6. application according to claim 1, is characterized in that, described Chinese medicine composition is capsule, tablet, pill, granule, oral liquid, drop pill, unguentum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511020011.7A CN105535414A (en) | 2015-12-30 | 2015-12-30 | Health food composition with gastric mucosal damage auxiliary protection function |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511020011.7A CN105535414A (en) | 2015-12-30 | 2015-12-30 | Health food composition with gastric mucosal damage auxiliary protection function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105535414A true CN105535414A (en) | 2016-05-04 |
Family
ID=55815323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511020011.7A Withdrawn CN105535414A (en) | 2015-12-30 | 2015-12-30 | Health food composition with gastric mucosal damage auxiliary protection function |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105535414A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106262806A (en) * | 2016-07-29 | 2017-01-04 | 金浩 | A kind of for food recovering mucosal lesion and preparation method thereof |
| CN108721557A (en) * | 2018-08-17 | 2018-11-02 | 完美（中国）有限公司 | A kind of Chinese medicine composition and its preparation method and application having assistant protection function to gastric mucosa damage |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457829A (en) * | 2003-04-17 | 2003-11-26 | 邯郸制药有限公司 | Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method |
| CN102670971A (en) * | 2012-06-28 | 2012-09-19 | 张祥明 | Chinese medicinal composition for treating chronic atrophic gastritis |
-
2015
- 2015-12-30 CN CN201511020011.7A patent/CN105535414A/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1457829A (en) * | 2003-04-17 | 2003-11-26 | 邯郸制药有限公司 | Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method |
| CN102670971A (en) * | 2012-06-28 | 2012-09-19 | 张祥明 | Chinese medicinal composition for treating chronic atrophic gastritis |
Non-Patent Citations (1)
| Title |
|---|
| 梁绍坤: "香砂温中汤治疗慢性萎缩性胃炎30例", 《光明中医》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106262806A (en) * | 2016-07-29 | 2017-01-04 | 金浩 | A kind of for food recovering mucosal lesion and preparation method thereof |
| CN108721557A (en) * | 2018-08-17 | 2018-11-02 | 完美（中国）有限公司 | A kind of Chinese medicine composition and its preparation method and application having assistant protection function to gastric mucosa damage |
| CN108721557B (en) * | 2018-08-17 | 2021-02-26 | 完美（中国）有限公司 | Traditional Chinese medicine composition with auxiliary protection function on gastric mucosa injury and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102861298A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103520577A (en) | Medicine-and-food dual-purpose preparation for treating pneumoconiosis, clearing away lung-heat and nourishing heart and preparation method for medicine-and-food dual-purpose preparation | |
| CN106362117A (en) | Traditional Chinese medicine composition capable of dispelling alcohol effect and nourishing liver and preparation method thereof | |
| CN104042802A (en) | Traditional Chinese medicine composition capable of treating fatty liver | |
| CN104338043B (en) | A kind of medicine for improving immunity and preparation method thereof | |
| CN102872261A (en) | Application of straw berry tomato in preparing medicine for treating acute cholecystitis | |
| CN105343755A (en) | Hawthorn stomach-nourishing traditional Chinese medicine composition and preparation method thereof | |
| CN101530563A (en) | Traditional Chinese medicine composition for treating gastric ulcer and preparation method thereof | |
| CN107095995B (en) | A pharmaceutical composition for treating gastritis and gastric ulcer, and its preparation method | |
| CN105535414A (en) | Health food composition with gastric mucosal damage auxiliary protection function | |
| CN104043077A (en) | Traditional Chinese medicine composition for tonifying qi and nourishing blood | |
| CN104958636A (en) | Medicinal composition for treating functional dyspepsia and preparation method of medicinal composition | |
| CN108721557B (en) | Traditional Chinese medicine composition with auxiliary protection function on gastric mucosa injury and preparation method and application thereof | |
| CN105477374A (en) | Healthy food composition with auxiliary protection function of gastric mucosal injury | |
| CN104984237A (en) | Traditional Chinese medicine composition and preparation method | |
| CN105056170A (en) | Application of traditional Chinese medicine composition in preparing drug for treating acute gastritis | |
| CN104162136A (en) | Traditional Chinese medicine granule for treating spleen and stomach cold hysteresis and preparation method of traditional Chinese medicine granule | |
| CN106309698A (en) | Traditional Chinese medicine composition for treating ichthyosis and preparation method thereof | |
| CN102772614A (en) | Menstruation regulating medicinal liquor | |
| CN103721229A (en) | Traditional Chinese medicinal composition for treating infantile cough and asthma and preparation method thereof | |
| CN103736054B (en) | A kind of Chinese medicine composition of protecting stomach lining and preparation method thereof | |
| CN111759901B (en) | Traditional Chinese medicine composition for treating functional abdominal pain of children and preparation method thereof | |
| CN105435189A (en) | Application of traditional Chinese medicine composition to preparation of drug for treating acute gastritis | |
| CN106474421B (en) | A kind of Chinese medicine composition that treating colorectal cancer and its application | |
| CN105456617A (en) | Oral-administrated traditional Chinese medicine pills for treating symptom of pathogenic fire derived from stagnation of liver and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160504 |